An intracellular approach to diagnostics
Changing the way diagnostics approach blood tests
First product detects Alzheimer’s disease before clinical symptoms appear
Pre Diagnostic’s first test will enable early detection of Alzheimer’s disease with an accurate, non-invasive, dynamic test, where the ongoing clearance of beta amyloid (Abeta) is measured. Abeta is considered to be the first hallmark of Alzheimer’s disease, and our test is the only blood test that measures the ongoing disease pathology demonstrated by Abeta clearance.
Pre Neurolab
Pre Neurolab Laboratory, a subsidiary of Pre Diagnostics AS, specializes in providing analytical biomarker services primarily focused on neurodegenerative diseases. Established in 2022 with a state-of-the-art laboratory located in Oslo, Norway, we are equipped to support a wide range of research biomarker studies using our advanced immunoassay platforms. Our services can accommodate studies involving sample sizes ranging from 50 to several thousands.
